BeiGene (ONC) EBITDA

annual EBITDA:

-$396.44M+$723.62M(+64.61%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ONC annual EBITDA is -$396.44 million, with the most recent change of +$723.62 million (+64.61%) on December 31, 2024.
  • During the last 3 years, ONC annual EBITDA has risen by +$995.84 million (+71.53%).
  • ONC annual EBITDA is now -12497.30% below its all-time high of -$3.15 million, reached on December 1, 2013.

Performance

ONC EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherONCincome statement metrics

quarterly EBITDA:

$43.91M+$73.08M(+250.47%)
March 1, 2025

Summary

  • As of today (May 29, 2025), ONC quarterly EBITDA is $43.91 million, with the most recent change of +$73.08 million (+250.47%) on March 1, 2025.
  • Over the past year, ONC quarterly EBITDA has increased by +$279.96 million (+118.60%).
  • ONC quarterly EBITDA is now -62.22% below its all-time high of $116.20 million, reached on September 1, 2017.

Performance

ONC quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherONCincome statement metrics

TTM EBITDA:

-$116.48M+$279.96M(+70.62%)
March 1, 2025

Summary

  • As of today (May 29, 2025), ONC TTM EBITDA is -$116.48 million, with the most recent change of +$279.96 million (+70.62%) on March 1, 2025.
  • Over the past year, ONC TTM EBITDA has increased by +$888.39 million (+88.41%).
  • ONC TTM EBITDA is now -1373.63% below its all-time high of -$7.90 million, reached on September 1, 2014.

Performance

ONC TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherONCincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

ONC EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+64.6%+118.6%+88.4%
3 y3 years+71.5%+110.3%+93.9%
5 y5 years+57.9%+112.0%+89.8%

ONC EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+77.0%at high+109.7%at high+93.9%
5 y5-yearat high+77.0%-45.0%+107.9%at high+93.9%
alltimeall time<-9999.0%+77.0%-62.2%+107.9%-1373.6%+93.9%

ONC EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$43.91M(-250.5%)
-$116.48M(-70.6%)
Dec 2024
-$396.44M(-64.6%)
-$29.18M(-40.4%)
-$396.44M(-45.5%)
Sep 2024
-
-$48.97M(-40.4%)
-$727.23M(-8.0%)
Jun 2024
-
-$82.23M(-65.2%)
-$790.72M(-21.3%)
Mar 2024
-
-$236.06M(-34.4%)
-$1.00B(-10.3%)
Dec 2023
-$1.12B(-35.0%)
-$359.98M(+220.1%)
-$1.12B(-7.5%)
Sep 2023
-
-$112.46M(-62.1%)
-$1.21B(-20.4%)
Jun 2023
-
-$296.38M(-15.6%)
-$1.52B(-7.7%)
Mar 2023
-
-$351.25M(-22.1%)
-$1.65B(-4.4%)
Dec 2022
-$1.72B(+23.8%)
-
-
Dec 2022
-
-$450.61M(+6.7%)
-$1.72B(-5.9%)
Sep 2022
-
-$422.16M(-0.4%)
-$1.83B(-1.5%)
Jun 2022
-
-$423.94M(-0.6%)
-$1.86B(-2.1%)
Mar 2022
-
-$426.69M(-23.6%)
-$1.90B(+36.4%)
Dec 2021
-$1.39B(-14.4%)
-$558.62M(+24.1%)
-$1.39B(+6.2%)
Sep 2021
-
-$450.15M(-2.8%)
-$1.31B(+1.4%)
Jun 2021
-
-$463.31M(-680.6%)
-$1.29B(+9.5%)
Mar 2021
-
$79.80M(-116.7%)
-$1.18B(-27.4%)
Dec 2020
-$1.63B(+72.7%)
-$477.08M(+10.5%)
-$1.63B(+6.3%)
Sep 2020
-
-$431.79M(+23.0%)
-$1.53B(+8.8%)
Jun 2020
-
-$351.01M(-4.1%)
-$1.41B(+23.6%)
Mar 2020
-
-$366.01M(-3.8%)
-$1.14B(+20.8%)
DateAnnualQuarterlyTTM
Dec 2019
-$941.27M(+35.4%)
-$380.55M(+23.5%)
-$941.27M(+12.3%)
Sep 2019
-
-$308.24M(+275.3%)
-$838.17M(+23.5%)
Jun 2019
-
-$82.14M(-51.8%)
-$678.58M(-10.4%)
Mar 2019
-
-$170.34M(-38.6%)
-$757.15M(+8.9%)
Dec 2018
-$695.38M(+642.1%)
-$277.44M(+86.6%)
-$695.38M(+33.8%)
Sep 2018
-
-$148.66M(-7.5%)
-$519.68M(+103.9%)
Jun 2018
-
-$160.71M(+48.0%)
-$254.82M(+68.1%)
Mar 2018
-
-$108.56M(+6.7%)
-$151.59M(+61.8%)
Dec 2017
-$93.70M(-18.6%)
-$101.74M(-187.6%)
-$93.70M(+225.9%)
Sep 2017
-
$116.20M(-302.2%)
-$28.75M(-84.0%)
Jun 2017
-
-$57.48M(+13.4%)
-$179.28M(+22.9%)
Mar 2017
-
-$50.68M(+37.7%)
-$145.93M(+26.7%)
Dec 2016
-$115.15M(+108.6%)
-$36.80M(+7.2%)
-$115.15M(+9.0%)
Sep 2016
-
-$34.32M(+42.2%)
-$105.67M(+24.8%)
Jun 2016
-
-$24.14M(+21.3%)
-$84.64M(+29.2%)
Mar 2016
-
-$19.89M(-27.2%)
-$65.50M(+18.7%)
Dec 2015
-$55.20M(+288.7%)
-$27.32M(+105.4%)
-$55.20M(+74.1%)
Sep 2015
-
-$13.30M(+166.2%)
-$31.70M(+20.5%)
Jun 2015
-
-$5.00M(-47.9%)
-$26.31M(+23.4%)
Mar 2015
-
-$9.59M(+151.5%)
-$21.31M(+81.9%)
Dec 2014
-$14.20M(+351.2%)
-$3.81M(-51.7%)
-$11.72M(+48.3%)
Sep 2014
-
-$7.90M
-$7.90M
Dec 2013
-$3.15M
-
-

FAQ

  • What is BeiGene annual EBITDA?
  • What is the all time high annual EBITDA for BeiGene?
  • What is BeiGene annual EBITDA year-on-year change?
  • What is BeiGene quarterly EBITDA?
  • What is the all time high quarterly EBITDA for BeiGene?
  • What is BeiGene quarterly EBITDA year-on-year change?
  • What is BeiGene TTM EBITDA?
  • What is the all time high TTM EBITDA for BeiGene?
  • What is BeiGene TTM EBITDA year-on-year change?

What is BeiGene annual EBITDA?

The current annual EBITDA of ONC is -$396.44M

What is the all time high annual EBITDA for BeiGene?

BeiGene all-time high annual EBITDA is -$3.15M

What is BeiGene annual EBITDA year-on-year change?

Over the past year, ONC annual EBITDA has changed by +$723.62M (+64.61%)

What is BeiGene quarterly EBITDA?

The current quarterly EBITDA of ONC is $43.91M

What is the all time high quarterly EBITDA for BeiGene?

BeiGene all-time high quarterly EBITDA is $116.20M

What is BeiGene quarterly EBITDA year-on-year change?

Over the past year, ONC quarterly EBITDA has changed by +$279.96M (+118.60%)

What is BeiGene TTM EBITDA?

The current TTM EBITDA of ONC is -$116.48M

What is the all time high TTM EBITDA for BeiGene?

BeiGene all-time high TTM EBITDA is -$7.90M

What is BeiGene TTM EBITDA year-on-year change?

Over the past year, ONC TTM EBITDA has changed by +$888.39M (+88.41%)
On this page